The global pharmacovigilance (PV) or drug safety market is projected to grow from $8.6bn in 2024 to $22.4bn by 2032.
Fundamental drivers shaping this growth include:
- Growing levels of drug consumption with increasing complexity of drugs being developed
- Increasingly stringent regulatory mandates and complex compliance requirements
- Technological advancements driving efficiencies in the PV market
- Continued trend of outsourcing in the pharma services industry, including of PV services
Anticipating an exciting growth outlook, the demand for pharmacovigilance (PV) is poised to fuel increased M&A activity.
To learn more about the key M&A trends taking shape this year in the pharmacovigilance space, read our latest paper.
DOWNLOAD THE FULL PAPER
If you would like to know more about the PV M&A landscape after reading this paper, or have any other questions on the wider pharmaceutical outsourcing space, please do get in touch - asultan@alvarezandmarsal.com.We would be delighted to discuss this report with you, including any implications these current and longer-term market themes may have on your business and overall shareholder objectives.
Shapes of European Fitness M&A Market
January 5, 2026
Europe’s fitness industry is moving into a new cycle: bigger, more digital, and closer than ever to healthcare. Our latest insights paper, unpacks how this full ecosystem is evolving and what it means for investors and strategic acquirers across operators, equipment, software and consumer brands.
Men’s Health M&A Market
December 15, 2025
In the UK, rapid digital health innovation and the government’s first-ever strategic response has meant that the men’s health sector is currently undergoing a shift that is breaking long-standing stigma and moving the market from low engagement to systemic change.
Alvarez & Marsal launches Public Company Advisory team and hires Corporate Finance Senior Director
December 1, 2025
London, 1 December 2025 – Leading global professional services firm Alvarez & Marsal (A&M) has bolstered its Corporate Finance practice with the launch of a new Public Company Advisory group and the appointment of Jamie Peel as a Senior Director in Manchester.
Neurodivergent Services M&A Market
September 29, 2025
Neurodiversity encompasses a spectrum of neurological conditions. With an estimated 1 in 7 people in the UK considered neurodivergent, demand for services is rising.
